The Clarendon Fund Managers team was out of the office and in the fresh air on Friday as we helped to rebuild part of the Bloody Bridge trail, a path leading up to Slieve Donard, in conjunction with the National Trust. This is all part of our ongoing team ESG initiative and we hope to continue volunteering in various guises […]
Bloody Bridge Trail Rebuild Read More »
Adoreboard, the leading Emotion AI platform, has enjoyed a record-breaking third quarter in 2022. The Belfast based technology company has met several key milestones this past quarter: Achieved 201% of the new business revenue target for the quarter, leading to significant expansion in total recurring revenue. Onboarded several new customers, including some of the world’s
Adoreboard celebrates record-breaking Q3 Read More »
Congratulations to our new portfolio company, CV6 Therapeutics, on securing a landmark £8m of equity and grant funding to support the commencement of first-stage clinical trials and further scientific development work on its first anti-cancer drug CV6-168. Article taken from: https://www.investni.com/ Pictured above are: Ian Greer, Robert Ladner and Mel Chittock. CV6 is dedicated to
CV6 Therapeutics to invest almost £8m in clinical trial for new anti-cancer drug. Read More »
Congratulations to portfolio company, Rock Extraction, on securing £500k to help them develop their Volt rock breaking tool, a cleantech alternative to explosives used in mining. Article taken from: https://www.irishnews.com/ Pictured above: Ian Dawson, Sian McLaughlin (Clarendon Fund Managers), Mervyn McCall , and Jon Houston. LISBURN engineering company Rock Extraction has secured £500,000 funding to
Lisburn engineering company Rock Extraction secures £500,000 funding! Read More »
The biotech start-up is using AI and machine learning techniques to discover new drugs, with its flagship programme tackling bovine mastitis. Articles taken from: https://www.siliconrepublic.com/ Pictured above: Anne Dornan, Stuart Gaffikin (Clarendon Fund Managers), Dermot Tierney, Ben Thomas, Chris Creevey, Peter Alexander, Jurnorain Gani and Sharon Huws. Belfast biotech start-up Amply Discovery has raised £900,000
QUB spin-out Amply Discovery raises £900,000 to find new drug products! Read More »
Ulster Bank has once again partnered with AwakenHub to deliver the second iteration of its popular SheGenerate programme, SheGen2.0. SheGen2.0 will provide targeted support for early-stage female founders and is particularly interested in supporting women who are interested in building their own business. Interested entrepreneurs have just days left to apply for a spot on
Providing support for early-stage female founders: SheGen2.0 Read More »
Congratulations to one of our portfolio company Modern Democracy on securing a £700k Investment! Article from: www.insidermedia.com A Derry/Londonderry-based election software company has secured a £700,000 investment which will facilitate further growth in the UK and international markets. Modern Democracy specialises in software designed to streamline the polling process. The team developed the Modern Polling
ELECTION SOFTWARE COMPANY SECURES £700K BOOST Read More »
Big congratulations to portfolio company, VascVersa Ltd, and its CEO Christina O’Neill and Chairman Aidan Courtney on recently securing an equity funding round of £500k. This funding will allow the company to accelerate the development of its product, Angicyte, which helps the body’s healing process in chronic non-healing wounds by making new blood vessels, which leads to improved
Innovative medical firm raises £500k in backing from investors Read More »
A nice article from our very own Stuart Gaffikin on the continued demand for equity funding from local businesses – we don’t see this changing as the pipeline of opportunities into quality high growth Northern Irish companies remains strong. Article from: sync.ni Demand for funding from early-stage businesses in Northern Ireland remains strong, with more than 20
High demand for cofund NI investment in second quarter of 2022 Read More »
Congratulations to portfolio company, Sonraí Analytics Ltd, for securing its ‘Seed Plus’ round with new lead investor Forward Partners. Exciting times ahead for this company as it seeks to reach more companies globally to translate precision medicine’s complex multi-omics data into real insights leading to better-personalised treatments for patients. Article from: sonraianalytics.com Sonrai Analytics, an emerging global